68 related articles for article (PubMed ID: 32450008)
1. Long noncoding RNA MAGI2-AS3/miR-218-5p/GDPD5/SEC61A1 axis drives cellular proliferation and migration and confers cisplatin resistance in nasopharyngeal carcinoma.
Cao C; Zhou S; Hu J
Int Forum Allergy Rhinol; 2020 Aug; 10(8):1012-1023. PubMed ID: 32450008
[TBL] [Abstract][Full Text] [Related]
2. LncRNA MAGI2-AS3 inhibites tumor progression by up-regulating STAM via interacting with miR-142-3p in clear cell renal cell carcinoma.
Yang R; Chen Z; Ao S; Liang L; Chen Z; Duan X; Zeng G; Deng T
Cell Signal; 2024 Jan; 113():110954. PubMed ID: 38084836
[TBL] [Abstract][Full Text] [Related]
3. LncRNA MAGI2-AS3-Encoded Polypeptide Restrains the Proliferation and Migration of Breast Cancer Cells.
Zhang Z; Yi Y; Wang Z; Zhang H; Zhao Y; He R; Luo Y; Cui Z
Mol Biotechnol; 2024 Jun; 66(6):1409-1423. PubMed ID: 37358745
[TBL] [Abstract][Full Text] [Related]
4. MiRNA-296-5p promotes the sensitivity of nasopharyngeal carcinoma cells to cisplatin via targeted inhibition of STAT3/KLF4 signaling axis.
Luo HQ; Wang Y; Ren J; Zhang QY; Chen Y; Chen MH; Huang NX; Wu MH; Tang XD; Li XY
Sci Rep; 2024 Mar; 14(1):6681. PubMed ID: 38509141
[TBL] [Abstract][Full Text] [Related]
5. LncRNA MIR100HG Promotes Cell Proliferation in Nasopharyngeal Carcinoma by Targeting miR-136-5p/IL-6 Axis.
Huang X; Zhong H; Cai Y
Mol Biotechnol; 2024 May; 66(5):1279-1289. PubMed ID: 38278928
[TBL] [Abstract][Full Text] [Related]
6. Nasopharyngeal carcinoma derived exosomes regulate the proliferation and migration of nasopharyngeal carcinoma cells by mediating the miR-99a-5p BAZ2A axis.
Zhou XJ; Xu HM; Huang GS; Lin BR
Braz J Otorhinolaryngol; 2024; 90(1):101343. PubMed ID: 37925811
[TBL] [Abstract][Full Text] [Related]
7. LncRNA NEAT1/let-7a-5p axis regulates the cisplatin resistance in nasopharyngeal carcinoma by targeting Rsf-1 and modulating the Ras-MAPK pathway.
Liu F; Tai Y; Ma J
Cancer Biol Ther; 2018 Jun; 19(6):534-542. PubMed ID: 29565706
[TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNA GUSBP11 Knockdown Alleviates Nasopharyngeal Carcinoma via Regulating miR-1226-3p/
Zhang X; Liu J; Ji M; Qi G; Qiao R
Cancer Biother Radiopharm; 2024 Mar; 39(2):133-143. PubMed ID: 35675666
[No Abstract] [Full Text] [Related]
9. THAP9-AS1 promotes nasopharyngeal carcinoma progression through targeted regulation of the miR-185-5p/SOX13 axis.
Mo J; Gong Z; Liu H; Zhou L; Zhao Y
Physiol Int; 2024 Mar; 111(1):19-34. PubMed ID: 38270621
[TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicles derived from paclitaxel-sensitive nasopharyngeal carcinoma cells deliver miR-183-5p and impart paclitaxel sensitivity through a mechanism involving P-gp.
Cui X; Chen Y; Zhao L; Ding X
Cell Biol Toxicol; 2023 Dec; 39(6):2953-2970. PubMed ID: 37296288
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia Induces Tumor-Derived Exosome SNHG16 to Mediate Nasopharyngeal Carcinoma Progression through the miR-23b-5p/MCM6 Pathway.
Hou W; Xu L; Su T; Wu Y; Liu Y; Wei Y
Appl Biochem Biotechnol; 2024 Jan; 196(1):275-295. PubMed ID: 37119503
[TBL] [Abstract][Full Text] [Related]
12. lncRNA MAGI2-AS3 overexpression had antitumor effect on Hepatic cancer via miRNA-23a-3p/PTEN axis.
Liu F; Deng W; Wan Z; Xu D; Chen J; Yang X; Xu J
Food Sci Nutr; 2021 May; 9(5):2517-2530. PubMed ID: 34026068
[TBL] [Abstract][Full Text] [Related]
13. Tumour-regulatory role of long non-coding RNA HOXA-AS3.
Chong ZX; Ho WY; Yeap SK
Prog Biophys Mol Biol; 2024 Jul; 189():13-25. PubMed ID: 38593905
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNAs PTENP1, GNG12-AS1, MAGI2-AS3 and MEG3 as tumor suppressors in breast cancer and their associations with clinicopathological parameters.
Záveský L; Jandáková E; Weinberger V; Minář L; Kohoutová M; Slanař O
Cancer Biomark; 2024; 40(1):61-78. PubMed ID: 38277283
[TBL] [Abstract][Full Text] [Related]
15. BMSC derived EVs inhibit colorectal Cancer progression by transporting MAGI2-AS3 or something similar.
Ma T; Wang M; Wang S; Hu H; Zhang X; Wang H; Wang G; Jin Y
Cell Signal; 2024 May; ():111235. PubMed ID: 38806109
[TBL] [Abstract][Full Text] [Related]
16. Deubiquitinase USP7 stabilizes KDM5B and promotes tumor progression and cisplatin resistance in nasopharyngeal carcinoma through the ZBTB16/TOP2A axis.
Zhang B; Li J; Wang Y; Liu X; Yang X; Liao Z; Deng S; Deng Y; Zhou Z; Tian Y; Wei W; Meng J; Hu Y; Wan C; Zhang Z; Huang F; Wen L; Wu B; Sun Y; Li Y; Yang K
Cell Death Differ; 2024 Mar; 31(3):309-321. PubMed ID: 38287116
[TBL] [Abstract][Full Text] [Related]
17. Expression analysis of necroptosis related genes and lncRNAs in patients with pituitary neuroendocrine tumors.
Askari A; Darabi MR; Eslami S; Jamali E; Sharifi G; Ghafouri-Fard S; Dilmaghani NA
Pathol Res Pract; 2024 Jun; 258():155332. PubMed ID: 38696856
[TBL] [Abstract][Full Text] [Related]
18. Expression of concern: 'Long non-coding RNA LINC00346 contributes to cisplatin resistance in nasopharyngeal carcinoma by repressing miR-342-5p' (2020), by Cui Z
Open Biology editorial team
Open Biol; 2023 Aug; 13(8):230304. PubMed ID: 37651285
[No Abstract] [Full Text] [Related]
19. Retraction Note: Long noncoding RNA RBMS3-AS3 acts as a microRNA-4534 sponge to inhibit the progression of prostate cancer by upregulating VASH1.
Jiang Z; Zhang Y; Chen X; Wu P; Chen D
Gene Ther; 2024 Mar; 31(3-4):197. PubMed ID: 38191703
[No Abstract] [Full Text] [Related]
20. Long noncoding RNA MAGI2-AS3 inhibits bladder cancer progression through MAGI2/PTEN/epithelial-mesenchymal transition (EMT) axis.
Shen D; Xu J; Cao X; Cao X; Tan H; Deng H
Cancer Biomark; 2021; 30(2):155-165. PubMed ID: 33104021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
